S-(BROMOMETHYL) (6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-6,9-DIFLUORO-11-HYDROXY-16-METHYL-3-OXO-17-(1-OXOPROPOXY)ANDROSTA-1,4-DIENE-17-CARBOTHIOATE
UNII KP2FZY6867
Substance Identification & Data
This profile provides standardized clinical and technical data for S-(bromomethyl) (6.alpha.,11.beta.,16.alpha.,17.alpha.)-6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KP2FZY6867.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80474-27-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H31BrF2O5S STSJMJBSSJPOIV-CENSZEJFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for S-(bromomethyl) (6.alpha.,11.beta.,16.alpha.,17.alpha.)-6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.